1. Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Republic of (South);
2. Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain;
3. Chris O'Brien Lifehouse, Sydney, Australia;
4. Segal Cancer Center, Jewish General Hospital, Rossy Cancer Network, McGill University, Montreal, QC, Canada;
5. Netherlands Cancer Institute, Amsterdam, Netherlands;
6. Blacktown Hospital, Sydney, Australia;
7. Département d’Innovation Thérapeutique et d’Essais Précoces, Gustave Roussy, Villejuif, France;
8. Lung Cancer Unit, Meir Medical Center, Kfar-Saba, Israel;
9. Rabin Medical Center, Petah Tikva, Israel;
10. Department of Oncology, Institut Claudius Regaud Institut Universitaire du Cancer-Oncopole, Toulouse, France;
11. Oscar Lambret Cancer Center, Lille, France;
12. Indiana University, Simon Cancer Center, Indianapolis, IN;
13. Merck & Co., Inc., Upper Gwynedd, PA;
14. Merck & Co., Inc., Rahway, NJ;
15. The University of Texas MD Anderson Cancer Center, Houston, TX;